Aniscal, Jobert R.
HRN: 22-19-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
11/16/2022
11/21/2022
PO
3 Ml
Q12
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes